Girentuximab (Anti-CA9 / Carbonic anhydrase 9)
Girentuximab (Anti-CA9 / Carbonic anhydrase 9) is a chimeric monoclonal antibody that targets and binds to carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC). MW:145.5 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2578 |
Sku # | A2578-1mg |
Pricing | 1mg, $270.00 |